Cost of illness of leukemia in Japan – Trend analysis and future projections

ConclusionCOI of leukemia increased from 1996 to 2014, but was projected to decrease in foreseeable future. With advancement of new therapies, leukemia has become potentially curable and require long-term care; so direct cost and morbidity cost will remain unchanged. This reveal the further continuing burden on public funds. Thus, the information obtained from this study can be regarded as beneficial to future policy making with respect to government policies in Japan.
Source: Journal of the Chinese Medical Association - Category: General Medicine Source Type: research